> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clarifies FDA-1571 Completion
- URL: https://www.fdaweb.com/fda-clarifies-fda-1571-completion/
- Published: 2019-06-25T12:00:00.000Z
- Updated: 2026-09-15T01:34:49.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5144417

FDA has clarified for small businesses when “research” versus “commercial” should be selected on FDA-1571 and thus when electronic common technical document requirements would apply for an IND application. In a podcast, CDER Office of New Drugs team leader **Paul Phillips** says a commercial IND is one for which the sponsor intends to commercialize the product by eventually submitting a marketing application. In contrast, a research IND is one for which the sponsor does not intend to later commercialize the product.

A CDER Small Business and Industry Assistance online [post](https://www.fda.gov/drugs/cder-small-business-industry-assistance-sbia/cder-sbia-chronicles?ref=fdaweb.com) explains the update and contains a link to the podcast.